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PURPOSE. Homeostatic turnover of the trabecular meshwork extracellular matrix (ECM) is
essential to regulate aqueous humor outflow and to maintain intraocular pressure
homeostasis. In this study, we evaluated aqueous humor turnover, intraocular pressure, and
trabecular meshwork organization in MMP-9 null mice.
METHODS. Intraocular pressure and aqueous humor turnover were measured in MMP-9 null
versus wild-type mice. Morphology of the anterior segment of the eye, with special
attention to the structural organization of the trabecular meshwork, was investigated by
means of optical coherence tomography, light microscopy, and transmission electron
microscopy. Furthermore, using quantitative real-time polymerase chain reaction and
immunostainings, we evaluated the ECM composition of the trabecular meshwork. Finally,
the integrity and function of the retina and optic nerve were assessed, via optical coherence
tomography, histologic techniques, and optomotor testing.
RESULTS. MMP-9 null mice displayed early-onset ocular hypertension and reduced aqueous
humor turnover. While transmission electron microscopic analysis did not reveal any
abnormalities in the cellular organization of the trabecular meshwork, detailed investigation
of collagen expression indicated that there is an aberrant trabecular meshwork ECM
composition in MMP-9 null mice. Notably, at the age of 13 months, no glaucomatous
neurodegeneration was seen in MMP-9 null mice.
CONCLUSIONS. Our observations corroborate MMP-9 as an important remodeler of the
collagenous composition of the trabecular meshwork and provide evidence for a causal
link between MMP-9 deficiency, trabecular meshwork ultrastructure, and ocular hyperten-
sion.
Keywords: intraocular pressure, matrix metalloproteinase-9, aqueous humor dynamics,
collagen
Glaucoma is one of the most common blinding diseases,affecting more than 60 million people worldwide.1,2
Although the disease presents as a neurodegenerative disorder
affecting retinal ganglion cell (RGC) axons in the optic nerve
and their somata in the retina, the elicitors of this optic
neuropathy are often located outside the neuroretina. Ocular
hypertension, resulting from disturbances in aqueous humor
turnover, is considered to be the major risk factor for the
development of glaucoma.
The intraocular pressure (IOP) is defined by the rate of
aqueous humor production by the ciliary body on the one
hand, and the aqueous humor outflow resistance via the
iridocorneal tissues (i.e., trabecular meshwork and Schlemm’s
canal) and the uveoscleral pathway, on the other hand. The
trabecular meshwork is largely responsible for the generation of
the outflow resistance via homeostatic turnover of its
extracellular matrix (ECM).3,4 This complex equilibrium of
ECM biosynthesis versus proteolysis is actualized by, among
others, members of the matrix metalloproteinase (MMP) family.
Matrix metalloproteinase-1, -2, -3, -9, -12, and -14, as well as
their endogenous inhibitors TIMP-1 to -4, are constitutively
expressed by trabecular meshwork cells.3,5–9 Their balanced,
concerted activity results in cleavage of the intricate super-
molecular organization of the trabecular ECM, thereby allowing
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endocytosis and intracellular degradation of these cleavage
products by the trabecular meshwork cells. In general,
mechanical stretching of the trabecular meshwork due to
IOP elevation, is believed to induce upregulated secretion of
MMPs, while reducing TIMPs. This altered MMP/TIMP balance
increases the trabecular ECM turnover rate, reduces the
aqueous outflow resistance, and restores normal IOP.10
Matrix metalloproteinases are a well-conserved family of
metzincin proteases. Based on either their structural organiza-
tion or their substrate preference, MMPs are categorized into
smaller subfamilies that together can cleave virtually all
components of the ECM.11–13 Matrix metalloproteinase-9
(gelatinase B, 92-kDa type IV collagenase) belongs to the
subfamily of the gelatinases. In general, MMP-9 is essential to
reproduction, growth and development, inflammation and
would healing, whereas it plays a detrimental role in many
inflammatory, infectious, degenerative, and vascular diseas-
es.13–15 In the eye, only one publication16 has described ocular
hypertension in MMP-9 null mice. In addition, MMP-9
deficiency has been reported to protect against detachment-
induced apoptosis of the RGCs in an ischemia–reperfusion
injury model.17 Other anomalies seen in MMP-9 null mice
include bone-development defects, delayed healing of bone
fractures, impaired vascular remodeling and reduced angio-
genesis, and defective neuronal remyelination after nerve
injury.13,15
In this study, we aimed to fully characterize the ocular
phenotype of MMP-9 null mice, with emphasis on the potential
dysregulation of IOP in these mice. Therefore, we performed a
detailed characterization of IOP homeostasis and aqueous
humor turnover, as well as a morphologic investigation of the
anterior segment of the eye. Special attention was given to the
structural organization of the trabecular meshwork, which was
investigated both at the light microscopic level and by means
of transmission electron microscopy. Furthermore, we evalu-
ated the qualitative ECM composition of the trabecular
meshwork, by means of quantitative real-time polymerase
chain reaction (qRT-PCR) and immunostainings. Finally, the
integrity of the retina and optic nerve was assessed to reveal
whether MMP-9 null mice suffer from ocular hypertension-
induced RGC degeneration.
MATERIALS AND METHODS
Experimental Animals
All studies were conducted in compliance with the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research, and were approved by the institutional ethical
committees. Wild-type and MMP-9 null (MMP-9/) mice in the
C57Bl6/N genetic background were obtained from the
university breeding colony and genotyped to confirm homo-
zygosity.18 Knockdown of MMP-9 was verified by using gelatin
zymography on tissue lysates of the anterior chamber angle
region (data not shown). Animals were kept under a 12/12-
hour light–dark cycle and had ad libitum access to food and
water.
Intraocular Pressure Measurement and
Pachymetry
A rebound tonometer (Tono-Lab; iCare, Helsinki, Finland) was
used to measure the IOP in anesthetized animals, according to
the manufacturer’s instructions. Intraocular pressure measure-
ments were taken between 3 and 5 minutes after induction of
anesthesia with avertin (intraperitoneal [i.p.] 15 mL/kg; Sigma-
Aldrich Corp., St. Louis, MO, USA). Following IOP measure-
ment, central corneal thickness (CCT) was assessed by using
an ultrasound pachymeter (Corneao Plus; Sonogage, Cleveland,
OH, USA), as previously described.19
Noninvasive Measurement of Aqueous Humor
Turnover
Aqueous humor turnover was measured noninvasively by
monitoring the rate of fluorescence decay from the aqueous
humor after topical instillation of fluorescein.20 Fluorescence
images were captured in 10-minute intervals for 1 hour, with a
stereomicroscope (Zeiss, Oberkochen, Germany). For each
image, the average pixel intensity in the green channel was
calculated by using Fiji software.21 The first fluorescence image
was used as the peak fluorescence (100%, t ¼ 0) for
normalizing all subsequent measurements. Experiments were
performed under general anesthesia with ketamine (i.p. 75 mg/
kg, Nimatek; Eurovet Animal Health, Bladel, the Netherlands)
and medetomidine (i.p. 1 mg/kg, Domitor; Janssen Pharma-
ceutica, Beerse, Belgium).
Spectral-Domain Optical Coherence Tomography
(SD-OCT)
Anterior segment morphology and thickness of the retinal
layers were evaluated in anesthetized mice, with an SD-OCT
system (Envisu R2210; Bioptigen, Morrisville, NC, USA).22
Spectral-domain OCT was performed by using 100 consecutive
B-scan lines composed of 1000 A-scans, in a 3.0 3 3.0-mm
(anterior segment) or 1.4 3 1.4-mm field (retina). Anterior
chamber depth, CCT, total retinal thickness, and thickness of
the ganglion cell complex were analyzed by using InVivoVue
Diver 2.2 software (Bioptigen).
Histologic Stainings
For histologic analysis of the retina, cornea, anterior segment,
and axon integrity, semithin 1-lm cross-sections were made.
Eyes were fixed overnight in cold 2% glutaraldehyde (in 150
mM saccharose, 50 mM sodium cacodylate [pH 7.3]),
followed by fixation in 2% osmium tetroxide (in 50 mM
sodium cacodylate [pH 7.3]) for 1 hour. After dehydration in a
graded acetone series, tissues were embedded in Araldite. Eye
sections were stained with 0.1% methylene blue and 0.1%
thionine (in 115 mM Na2HPO4.2H2O); optic nerve sections
were stained with 1% toluidine blue (in 500 mM sodium
borohydride).23 Images were taken with a light microscope
(Zeiss). Axonal integrity was qualitatively evaluated by using
the grading scale described by Jia et al. (five sections per
mouse).24,25 In addition, the radius of the optic nerve was
measured (three sections per mouse) and axon density
(number of axons/100 lm2) was semiautomatically computed
by using a validated sampling method (five frames of 7500
lm2 per mouse), based on the Particle Counter plugin for Fiji
software.21,23
For Picro Sirius Red staining of collagen, paraffin sections of
the eye were stained for 1 hour with Direct Red 80 (0.1% in
aqueous solution of picric acid; Sigma-Aldrich Corp.), followed
by 2 minutes rinsing in 0.01N HCl. Images were taken with a
polarized light microscope (Leica, Wetzlar, Germany). For
analysis of Sirius Red stainings, the iridocorneal tissue was
outlined and the average pixel intensity in the red and green
channel was analyzed in this region of interest (five sections
per mouse), using Fiji software.
A Verhoeff’s Van Gieson staining on paraffin sections was
used to visualize elastin fibers. Briefly, sections were incubated
for 20 minutes in Verhoeff’s Elastica (hematoxylin 5%, FeCl3
10%, lugol, in a 120:48:48 ratio), followed by 2 minutes in
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ferric chloride 2%, 2 minutes in ethanol 95%, and 6 minutes in
Van Gieson (acid fuchsin 1%, saturated picric acid, in a 1:45
ratio). Images were taken with a light microscope (Zeiss).
Quantification of RGC Survival via Brn3a
Immunostaining
Brna3 immunostaining was performed on retinal flat-
mounts.26,27 Briefly, whole mount retinas were frozen for 15
minutes at 808C, and the primary antibody goat anti-Brn3a
(1:750, C-20; Santa Cruz Biotechnology, Dallas, TX, USA) was
applied overnight. The next day, retinas were incubated with a
secondary antibody conjugated to Alexa fluorophore-488
(1:500; Life Technologies, Carlsbad, CA, USA) for 2 hours.
Mosaic z-stack images of the entire retina were taken with a
multiphoton microscope (Olympus, Tokyo, Japan). Retinal
ganglion cell density (number of Brn3aþ RGCs/mm2) and heat
maps representing a pseudocolor representation of RGC
density were automatically computed from whole mount
retinas, by using Fiji software and a recently described
semiautomated counting macro.28
Immunostainings for Collagens and Fibronectin
Immunostainings for fibronectin and collagen I and IV were
performed on 10-lm paraffin-embedded sections. Briefly,
antigen retrieval was performed by heating the sections in
citrate buffer for 20 minutes at 958C. Sections were incubated
for 20 minutes in 0.3% hydrogen peroxide (only for collagen
stainings), followed by a 1-hour blocking step with 20%
preimmune serum and overnight incubation with the primary
antibody (rabbit anti-collagen I, 1:500, ab34710, Abcam,
Cambridge, UK; rabbit anti-collagen IV, 1:400, 2150-1470,
AbD Serotec, Du¨sseldorf, Germany; rabbit anti-fibronectin,
1:100, F3648, Sigma-Aldrich Corp.). For the collagen stainings,
the secondary biotin-conjugated antibody (1:300; Dako,
Glostrup, Denmark) was applied for 45 minutes, and fluores-
cein isothiocyanate tyramide signal amplification was per-
formed according to the manufacturer’s instructions (Perkin-
Elmer, Waltham, MA, USA). For the fibronectin staining, an
Alexa fluorophore–conjugated secondary antibody (Life Tech-
nologies) was applied for 1 hour. Images were taken with a
confocal microscope (Olympus).
Transmission Electron Microscopy
Ultrathin (70 nm) transverse sections of Araldite-embedded
optic nerves were placed on 50 mesh copper grids, and double
stained with 4% uranyl acetate (in 50% ethanol) for 15 minutes
and 3% lead citrate for 4 minutes. Images were taken with an
EM900 transmission electron microscope (Zeiss). Trabecular
meshwork organization was analyzed on images of the entire
trabecular meshwork by using Fiji software. Thickness of
individual trabecular beams and the total trabecular meshwork
were measured at 30-lm increments along the length of the
trabecular meshwork. The intertrabecular space was marked
by background color filling. This area was then divided by the
length of the trabecular meshwork along which it was
analyzed, thus yielding a relative measure for intertrabecular
space.
Quantitative RT-PCR
Transcript levels of ECM molecules (collagen I, collagen IV,
elastin, and fibronectin), TIMPs (TIMP-1, -2, -3, and -4) and
compensatory MMPs (MMP-2, -3, and -13) were analyzed at
mRNA level with a qRT-PCR. Top1, Actb, and Gapdh were
selected from a list of five potential housekeeping genes by
using the geNorm reference gene analysis (Biogazelle, Ghent,
Belgium).29 Upon euthanization, the tissues of the iridocorneal
angle were quickly dissected and snapfrozen, followed by RNA
isolation with TRI Reagent (Sigma-Aldrich Corp.) and the
NucleoSpin RNA II kit (Macherey-Nagel, Du¨ren, Germany).
First-strand cDNA was synthetized from 250 ng RNA, using
Superscript III Reverse Transcriptase (Life Technologies). Next,
qRT-PCR was performed by using either SYBR Green Master-
mix (Thermo Fischer Scientific, Waltham, MA, USA) and 250
nM of both primers (for ECM molecules and TIMPs), or Maxima
Probe/ROX qPCR Master Mix (Life Technologies) and 125 nM
TaqMan PrimeTime qPCR Assay (for MMPs). Primers, probes
(Integrated DNA Technologies, Coralville, IA, USA), and
annealing temperatures are listed in Table 1. All samples were
run in triplicate with the StepOne Plus system (Applied
Biosystems, Foster City, CA, USA), and a no-template control
was added as negative control. Relative expression was
determined by using qBase software (based on the DDCT
method) (Biogazelle)30 and normalized against the geometric
mean of the housekeeping genes.
Statistics
For all data, normal distribution and parallel equal variance
between groups were tested. Intraocular pressure measure-
ments and pachymetry data were analyzed with a 2-way
ANOVA followed by Sidak’s multiple comparisons test.
Aqueous humor turnover data were analyzed by using a 2-
way repeated-measures ANOVA followed by Sidak’s multiple
comparisons test. Exponential decay constants were calculated
by least-squares regression analysis for exponential decay ([%
Intensity]¼ 100.ek.time). All other data were analyzed by using
a Student’s t-test. A probability level of <0.05 was accepted as
statistically significant (*P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001). All data are presented as mean 6 SEM.
Statistical analyses were performed with GraphPad Prism 6
(GraphPad Software, La Jolla, CA, USA).
RESULTS
Intraocular Pressure Homeostasis and Aqueous
Humor Dynamics
Measurements of the IOP confirmed that in each age group
studied, MMP-9 null mice had a significantly higher IOP than
age-matched wild-type mice (P < 0.0001). A 27%, 37%, 50%,
and 40% increase was observed at the age of 2 to 3, 3 to 4, 6 to
8 and 9 to 12 months (Fig. 1a). Of note, ultrasound pachymetry
excluded a difference in CCT between wild-type and MMP-9
null mice (Fig. 1b). Furthermore, fluorophotometric measure-
ments of aqueous humor dynamics at the age of 13 months
revealed that aqueous humor turnover was significantly
delayed in MMP-9 null animals, as shown by a lower
exponential decay constant (0.006 min1, R2 ¼ 0.82) in
comparison to wild-type mice (0.011 min1, R2 ¼ 0.98) (P <
0.05). Multiple comparisons analysis indeed revealed signifi-
cantly higher fluorescence intensities in MMP-9 null than in
wild-type mice at 20 (P < 0.01), 30 (P < 0.05), 40 (P < 0.05),
and 50 minutes (P < 0.05) post application of fluorescein
(Figs. 1c, 1d).
Anterior Segment Morphology
Next, potential malformations at the level of the iridocorneal
angle were evaluated in wild-type and MMP-9 null mice at the
age of 13 months. Spectral-domain OCT imaging of the anterior
segment of the eye confirmed that neither the wild-type nor
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the MMP-9 null mice had a closed iridocorneal angle, and also
anterior chamber depth did not differ (Figs. 2a, 2b). An
additional light microscopy histologic survey on transverse
sections of the eye revealed a normal ciliary body, well-defined
trabecular meshwork, and a patent Schlemm’s canal in all mice
(Fig. 2c).
Trabecular Meshwork Ultrastructure and ECM
Composition
Together, the above findings indicate that the underlying cause
of the observed ocular hypertension in MMP-9 null mice might
be due to abnormalities on an ultrastructural level, for
example, the (sub)cellular organization and/or ECM composi-
tion of the iridocorneal angle. Nevertheless, transmission
electron microscopy revealed giant vacuoles in the inner wall
endothelium of Schlemm’s canal, indicating a pressure gradient
and aqueous humor outflow, in both wild-type and MMP-9 null
mice (Fig. 3a). Furthermore, morphometric analysis of the
thickness of individual trabecular beams and the total thickness
of the trabecular meshwork, as well as the intertrabecular
space, did not reveal any difference in the laminar organization
of the trabecular meshwork in wild-type and MMP-9 null mice
(Fig. 3b). As such, the overall organization of the trabecular
meshwork does not seem to be affected by MMP-9 deficiency.
In contrast, qRT-PCR analysis of collagen transcript levels
unveiled that collagen I (Col1a1; P ¼ 0.064) and collagen IV
(Col4a3; P ¼ 0.067) expression tended to be lower in MMP-9
null mice (Figs. 4a, 4d). Immunostainings on transverse
sections of the anterior segment of the eyes confirmed a
prominent decrease in collagen I expression in the ECM in
MMP-9 null mice (Figs. 4b, 4c). In contrast, collagen IV
differences in immunolabeling were less pronounced and
confined to basal laminae (Figs. 4e, 4f). Furthermore, analysis
of Sirius Red staining on adjacent sections showed, first, a
slight decrease (~20%) in total collagen staining in the
trabecular meshwork of MMP-9 null mice (P < 0.05), and
second, an altered ratio of mature versus immature collagen.
Indeed, an increased accumulation of mature collagen (P <
0.005) was seen in the trabecular meshwork of MMP-9 null
mice, while immature collagen was significantly decreased (P
< 0.05) (Figs. 5a–c).
Expression analysis of elastin and fibronectin, using qRT-
PCR and (immuno)histologic stainings, did not reveal any
significant differences in expression between wild-type and
MMP-9 null mice (Supplementary Fig. S1).
TABLE 1. Sequences of qRT-PCR Primers, Probes, and Annealing Temperatures
Probe/Primer Sequence
Annealing
Temperature
SYBR Green assays
Musm_Eln_F 50-TGGTGACATGATCCCTCTCTCTT-30 62.58C
Musm_Eln_R 50-CCAGGGTGTCCCAGATGTG-30
Musm_Fn1_F 50-ATCATTTCATGCCAACCAGTT-30 59.58C
Musm_Fn1_R 50-TCGCACTGGTAGAAGTTCCA-30
Musm_Col1a1_F 50-CGATGGATTCCCGTTCGAGT-30 60.58C
Musm_Col1a1_R 50-CGATCTCGTTGGATCCCTGG-30
Musm_Col4a3_F 50-TGTGGATGCACGGTGTGTT-30 62.58C
Musm_ Col4a3_R 50-GTTCTCTTCACGGTGTGCTTGA-30
Musm_Timp1_F 50-CCAGAACCGCAGTGAAGAGT-30 57.08C
Musm_Timp1_R 50-GTACGCCAGGGAACCAAGAA-30
Musm_Timp2_F 50-CAGCCTCTCCCGTCTTTTGT-30 60.58C
Musm_Timp2_R 50-GTGGCTAGAAACCCCAGCAT-30
Musm_Timp3_F 50-GGACAGACTTGAGGTGAGGC-30 62.58C
Musm_Timp3_R 50-AGACCTCAAAAGCCGACTGG-30
Musm_Timp4_F 50-TTTGACCATCACCACCTGCTGT-30 64.58C
Musm_ Timp4_R 50-ACTTCAGCCAAACAGCCCACTC-30
Musm_Actb_F 50-CGAGCGTGGCTACAGCTTCA-30 60.58C
Musm_Actb_R 50-GAGCCACCGATCCACACAGA-30
Musm_Gapdh_F 50-TTCACCACCATGGAGAAGGC-30 62.58C
Musm_Gapdh_R 50-GGCATGGACTGTGGTCATGA-30
Musm_Top1_F 50-TGCCAGAGAGTGTCAAGTTT-30 59.58C
Musm_Top1_R 50-GCTCATCTGTGTAAAGTCGC-30
Musm_Gusb_F 50-GTATGAACGGGAAGCAATCC-30 59.08C
Musm_Gusb_R 50-AATCCCATTCACCCACACAA-30
Musm_Ywhaz_F 50-ACCCATCTTCCTTTACAACTCA-30 64.58C
Musm_Ywhaz_R 50-CATCCTGCTGTCCATTGCTTA-30
TaqMan assays
Mmp2 (Mm.PT.58.9606100) 50- /56-FAM/CACCCTTGA/ZEN/AGAAGTAGCTATGACCACC/3IABkFQ/ -30 60.08C
Musm_Mmp2_F 50-AACTTCACGCTCTTGAGACTT-30
Musm_Mmp2_R 50-GAATGCCATCCCTGATAACCT-30
Mmp3 (Mm.PT. 58.9719290) 50- /56-FAM/TGGTTGCTG/ZEN/CTCATGAACTTGGC/3IABkFQ/ -30 60.08C
Musm_Mmp3_1_F 50-GATGAACGATGGACAGAGGATG-30
Musm_Mmp3_1_R 50-TGTGGAGGACTTGTAGACTGG-30
Mmp13 (Mm.PT.58.42286812) 50- /56-FAM/AGGGCTGGG/ZEN/TCACACTTCTCTG/3IABkFQ/ -30 60.08C
Musm_Mmp13_F 50-AGACTGGTAATGGCATCAAGG-30
Musm_Mmp13_R 50-GCCATTTCATGCTTCCTGATG-30
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Implications of MMP-9 Deficiency on Retinal
Integrity
Given the IOP elevation observed in MMP-9 null animals, we
next investigated whether these mice exhibit a glaucoma-like
phenotype, that is, whether they exhibit RGC degeneration
and/or optic neuropathy. Analysis of total retinal thickness and
thickness of the ganglion cell complex (GCC, i.e., the sum of
the nerve fiber layer, RGC layer, and inner plexiform layer) on
SD-OCT images of the retina revealed no difference between
wild-type and MMP-9 null mice at the age of 13 months (Figs.
6a, 6b). Furthermore, qualitative assessment of retinal mor-
phology on transverse sections of the retina did not show any
abnormalities (Fig. 6e). In line with these observations,
evaluation of RGC density on retinal whole mounts did not
disclose any differences between wild-type and MMP-9 null
mice, in either young mice (3 months) or old mice (13 months)
(Figs. 6c, 6d). Finally, little to no signs of glaucomatous optic
neuropathy were seen on toluidine blue–stained semithin
sections of the optic nerve (Fig. 6h). Qualitative one-to-five
FIGURE 1. MMP-9 null mice exhibit elevated IOP owing to reduced aqueous humor drainage. (a) Longitudinal follow-up of IOP in wild-type and
MMP-9 null mice revealed that IOP elevation already manifests from the age of 2 months and persists at all ages measured thereafter, in MMP-9 null
mice (n ‡ 8, 2-way ANOVA, P < 0.0001). (b) Ultrasound pachymetry revealed no difference in CCT between wild-type and MMP-9 null mice (n ‡ 8,
2-way ANOVA). (c) Fluorophotometric measurements revealed that aqueous humor turnover is delayed in MMP-9 null animals (age 13 months) (n¼
5, 2-way repeated-measures ANOVA, P < 0.05). (d) Representative series of fluorescence images captured from wild-type and MMP-9 null mice at
10-minute intervals after application of fluorescein. Scale bar: 1 mm.
FIGURE 2. MMP-9 null mice exhibit normal overall anterior segment morphology. (a) Spectral- domain OCT imaging of the anterior segment of the
eye showed an open iridocorneal angle (*) in all mice under study. (b) In addition, morphometric analysis of the anterior chamber depth (arrow)
indicated that there is no difference between wild-type and MMP-9 null mice (age 13 months) (n ‡ 13, Student’s t-test). Scale bar: 500 lm. (c)
Postmortem histologic analysis of the anterior segment revealed no overt changes in the ciliary body (cb), trabecular meshwork (tm), and
Schlemm’s canal (sc) of MMP-9 null mice (n ¼ 5) as compared to age-matched wild-type mice (n¼ 7). Scale bar: 50 lm.
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grading of axonal integrity resulted in equal scores for wild-
type and MMP-9 null mice. Moreover, the optic nerve radius
(143 6 9 lm versus 162 6 4 lm, respectively) and axonal
density (39 6 5 axons/100 lm2 versus 44 6 13 axons/100
lm2, respectively) did not differ between wild-type and MMP-9
null mice (Figs. 6f, 6g).
Expression Profiling of TIMPs and Selected MMPs
in MMP-9 Null Mice
Enzymatic redundancy and compensation have been suggested
as underlying causes for the—often surprisingly—subtle
phenotypes of MMP-deficient mice.13 Following a literature
search and analysis of MMP substrate repertoires, we selected
MMP-2, MMP-3, and MMP-13 as the most plausible candidates
for compensation of MMP-9 enzymatic activities in MMP-9 null
mice. We performed a qRT-PCR expression analysis of these
MMPs in iridocorneal angle tissue extracts and found that for
all three MMPs, mRNA expression levels tended to be lower in
MMP-9 null mice (P < 0.05 for Mmp13) (Table 2). These
results thus preclude compensatory transcription of these
MMPs. Second, we also evaluated coregulation of TIMP
expression. Whereas mRNA levels of Timp1, Timp2, and
Timp3 were equal in wild-type and MMP-9 null mice, a
significant elevation (~80% increase; P < 0.05) was seen for
Timp4 in the anterior chamber angle tissue of MMP-9 null
mice. Thus, no coincidental decrease in TIMP levels, which
could compensate for decreased MMP(9) activity, was found.
DISCUSSION
MMP-9 Plays an Essential Role in Maintaining the
Ultrastructural Organization of the Trabecular
Meshwork
In accordance with earlier reports,16 the present results
demonstrated that MMP-9 null mice exhibit early-onset ocular
hypertension. In vivo measurements of aqueous humor
dynamics indicated that this ocular hypertension is related to
a decreased aqueous humor turnover, which could either be
the result of increased aqueous humor production or increased
outflow resistance. Given the aberrant collagen composition of
the iridocorneal angle that we observed in this study in MMP-9
null mice and other correlations between MMP-9, trabecular
meshwork ECM remodeling, and regulation of aqueous humor
outflow resistance,10 we postulate that the underlying cause of
the ocular hypertension observed in MMP-9 null mice is an
increased aqueous humor outflow resistance generated in the
trabecular meshwork. This rationale is further supported by
our SD-OCT and light microscopy analyses, which did not
unveil any abnormalities of the iridocorneal angle, ciliary body,
trabecular meshwork, or Schlemm’s canal in MMP-9 null mice.
The underlying cause for the increased outflow resistance
observed in MMP-9 null mice should thus reside in the
ultrastructural architecture/composition of the trabecular
meshwork. Indeed, while transmission electron microscopy
revealed no difference in the organization of the trabecular
beams and intertrabecular space, combined data from qRT-PCR
and immunostainings for collagen I and detailed analysis of
Sirius Red stainings indicated a differential ECM composition
and disturbed ECM turnover in MMP-9 null mice. From these
findings, we hypothesize that MMP-9 deficiency results in
reduced degradation of mature collagen fibers in MMP-9 null
mice, which in turn negatively affects de novo synthesis of
(immature) collagen (Fig. 5c). Indeed, the resultant accumula-
tion of mature collagen fibers in the iridocorneal angle of MMP-
9 null mice is reflected in the more intense labeling of mature
collagen in the Sirius Red stainings, while the negative
feedback regulation of collagen transcription can be seen in
the reduced levels of Col1a1 and Col4a3 mRNA and the
attenuated amount of immature collagen after analysis of Sirius
Red stainings. Notably, although the collagen I antibody used in
this study was produced by using the full collagen polypeptide
as an immunogen, and should therefore bind to both
FIGURE 3. MMP-9 null mice exhibit normal laminar organization of the trabecular meshwork. (a) Representative transmission electron microscopy
images of the trabecular meshwork of wild-type and MMP-9 null mice, illustrating normal laminar organization of the trabecular meshwork and the
presence of giant vacuoles (gv) in the inner wall endothelium of Schlemm’s canal (sc). Scale bar: 2 lm. (b) Morphometric analysis did not detect
any difference in the thickness of the trabecular beams (tb), the trabecular meshwork, or the intertrabecular space (n ‡ 3, Student’s t-test).
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monomeric and fibrillar forms of collagen I, our results suggest
that an increase in mature collagen I (fibrils) coincides with
reduced immunoreactivity. This leads us to believe that the
reduced immunoreactivity might be the result of cryptic
epitopes exclusively buried within the structure of the fibrillar
form, as has been described before for other polypeptides that
form mono-/oligomeric and fibrillar assemblies.31
Several lines of evidence point out that the trabecular
meshwork ECM is indeed the source of aqueous humor
outflow resistance, and that MMP-9 is a potent modulator of
the trabecular meshwork architecture. Ultrastructural exami-
nations of the trabecular meshwork of POAG patients reveal a
shift in ECM composition as well as decreased MMP-9 activity,
and a reciprocal interplay between both.32–34 Furthermore,
overexpression of the matricellular protein SPARC in human
anterior segment explant cultures results in elevated IOP and
qualitative changes in the ECM of the trabecular meshwork
(i.e., elevated collagen I, IV, and VI; laminin; and fibronectin
FIGURE 4. Collagen synthesis is affected in MMP-9 null mice. (a) qPCR analysis of Col1a1 mRNA expression reveals a (nonsignificant) reduction of
approximately 50% in collagen I synthesis in MMP-9 null mice in comparison to wild-type mice (n¼ 6, Student’s t-test). (b) Overview picture of a
collagen I immunostaining of the anterior chamber angle region, showing reduced collagen I expression in the trabecular meshwork and the sclera
of MMP-9 null mice. Scale bar: 50 lm. (c) High-magnification image of collagen I staining in the trabecular meshwork, revealing nearly complete
absence of collagen I staining in the trabecular beams of MMP-9 null mice (*). Scale bar: 10 lm. (d) qPCR analysis of Col4a3 mRNA expression
reveals a (nonsignificant) reduction of approximately 50% in collagen IV synthesis in MMP-9 null mice in comparison to wild-type mice (n ¼ 6,
Student’s t-test). (e) Overview picture of collagen IV immunostaining of the anterior chamber angle region reveals that immunostaining intensity is
slightly reduced in the trabecular meshwork of MMP-9 null mice. Scale bar: 50 lm. (f) High-magnification image of collagen IV staining in the
trabecular meshwork confirms reduced collagen IV immunolabeling. Scale bar: 10 lm.
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levels) that could be linked to a shift in MMP/TIMP balance and
a selective decrease in MMP-9 activity.33,35 This evidence for an
important role for MMP-9 in IOP homeostasis has been
corroborated by in vitro experiments using perfused human
anterior segment organ cultures, to which addition of
recombinant MMP-9 results in a reversible increase in outflow
facility.36 Notably, increased concentrations of TIMP-4 have
been found in the aqueous humor of POAG patients,37,38
supposedly adding to the imbalance in the MMP/TIMP molar
ratio. Despite a proven correlation with ocular hypertension, it
remains unresolved whether these changes are a cause or
consequence of the disease and whether TIMP levels increase
in response to altered MMP secretion or vice versa. Notably,
several MMP-independent activities have been proposed for
TIMPs, including TIMP-4, such as regulation of cell growth,
differentiation, migration, and apoptosis.39 In the context of
the trabecular meshwork, these actions could directly inhibit
cell contractibility and phagocytosis, and/or lead to the loss of
cellularity that has been observed within the POAG trabecular
meshwork, thereby affecting aqueous humor drainage.37,38 In
conclusion, although TIMP-4 is a known inhibitor of MMP-9,40
it remains elusive to what extent it is involved in the aberrant
collagen turnover that we observed in the trabecular mesh-
work of MMP-9 null mice. Continued research is required to
FIGURE 5. Sirius Red staining on sections of the iridocorneal angle reveals a disturbed collagen turnover in MMP-9 null mice. (a, b) Sirius Red
staining reveals immature collagen (i.e., non–cross-linked collagen monomers) in red, and mature collagen (i.e., cross-linked bundles of collagen
fibers) in green. Scale bar: 50 lm. (c) MMP-9 null mice display an altered ratio of immature versus mature collagen, compared to wild-type animals:
more mature collagen and less immature collagen is seen (n ¼ 6; Student’s t-test). (d) These observations could be explained by the hypothesis
schematically depicted here. Owing to the lack of MMP-9 proteolytic activity in MMP-9 null mice, degradation of mature collagen is impeded. As a
result of feedback signaling mechanisms, this results in an increased suppression and/or decreased activation of collagen gene transcription, which
leads to a lowered synthesis of immature collagen monomers.
Trabecular Meshwork Organization in MMP-9 Null Mice IOVS j November 2016 j Vol. 57 j No. 14 j 5991
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/Journals/IOVS/935850/ on 11/13/2016
uncover the biological effects of the increased TIMP-4
expression, with respect to its potential effects on both ECM
composition and on the cellular organization of the trabecular
meshwork. The exact role of collagens in the regulation of
outflow resistance remains unclear, yet evidence for a crucial
effect on IOP homeostasis is emerging. Whereas type I, III, and
IV collagen fibers are constituents of the basement membrane–
like material in the intercellular space of the trabecular
meshwork and confer tensile strength to the tissue, collagen
types III and VI are found in the sheets of the elastic fibers that
allow expansion and recoil of the trabecular meshwork in
response to IOP fluctuations.41,42 Notably, POAG and aging are
associated with structural changes in the trabecular meshwork,
including accumulation of both type VI collagen and elastic
fiber sheet material.43–48 Furthermore, disorganization of the
collagenous ECM appears to be a common theme in several
transgenic mouse lines displaying ocular hypertension and
glaucomatous neurodegeneration. In Cyp1b1/mice, irregular
collagen distribution in the trabecular meshwork and elevated
IOP are seen, resembling the abnormalities in the trabecular
FIGURE 6. MMP-9 null mice exhibit no signs of retinal atrophy or optic neuropathy. (a, b) Morphometric analysis of the thickness of the total retina
(TR, arrow) and the thickness of the GCC (arrow) on SD-OCT images of the retina revealed no significant differences between 13-month-old wild-
type (n¼15) and MMP-9 null mice (n¼13) (Student’s t-test). Scale bar: 50 lm. (c, d) Retinal ganglion cell density, quantified as the number of Brn3aþ
cells per mm2 retina and represented via pseudocolor density mapping here, was similar in wild-type and MMP-9 null mice and did not change
between the age of 3 and 13 months (Student’s t-test). Scale bar: 1 mm. (e) Postmortem histologic analysis of the retina revealed no overt changes in
cytoarchitecture of 13-month-old wild-type mice (n¼7) versus age-matched MMP-9 null mice (n¼5). Scale bar: 20 lm. (f) Measurements of the optic
nerve diameter revealed no difference between 13-month-old wild-type (n¼ 7) and MMP-9 null mice (n¼ 6) (Student’s t-test). (g) Quantification of
axonal density in the optic nerves of 13-month-old wild-type (n¼ 7) and MMP-9 null mice (n¼ 6) revealed no effect of MMP-9 deficiency on axonal
integrity (Student’s t-test). (h) Toluidine blue staining on optic nerve cross-sections of wild-type and MMP-9 null mice. Scale bar: 10 lm.
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meshwork of human primary congenital glaucoma pa-
tients.42,49 Trabecular meshwork collagen fibrils have also
been found to be larger and more irregular in thrombospondin-
1 and -2 null mice, which display decreased IOP.50 Notably,
thrombospondin-1, -2, and SPARC have been shown to
modulate MMP levels.51 Finally, the transgenic Colla1r/r
mouse—with a targeted mutation in the Colla1 gene,
abolishing the consensus cleavage site for MMP-1, -2, and
potentially other MMPs—displays gradual IOP elevation and
axonal degeneration.52,53 This has been attributed to an age-
dependent accumulation of collagen I in the outflow
pathways, due to inhibition of fibrillar collagen turnover, and
a reduced outflow facility is found in these mice.52,54 Taken
together, disruption of collagen fibers in the trabecular
meshwork may decrease tissue elasticity, alter the shape and
cytoskeletal organization of trabecular meshwork cells, and
affect expansion–recoil of the trabecular spaces, leading to a
compromised aqueous humor outflow and disturbed IOP
homeostasis. Of note, a coinvolvement of trabecular and
uveoscleral outflow pathways seems plausible, as the observed
imbalance of collagen turnover in both these tissues will
impede aqueous humor outflow via either route.54
The Role of MMP-9 in the Retina Seems to Be
Limited to a Detrimental Function
As elevated IOP is the major risk factor for glaucoma, we
hypothesized that the MMP-9 null mice would be predisposed
to develop glaucomatous optic neuropathy. We therefore
analyzed total retinal thickness to check for overall retinal
atrophy, GCC thickness and RGC density to assess RGC
degeneration, and axon density in the optic nerve to evaluate
axonal integrity. Taken together, none of these analyses
revealed any signs of glaucomatous neurodegeneration in the
retina or optic nerve of MMP-9 null and wild-type mice. These
results are in line with the surprisingly subtle phenotypes that
have been described in many other MMP null mouse lines, and
that have been attributed to enzymatic redundancy, enzymatic
compensation, and adaptive development.13
Nevertheless, several genetic mouse models for glaucoma
have shown that IOP elevations of the magnitude observed in
this study are sufficient to induce optic neuropathy, although
these IOP elevations all manifested at later ages. This is the
case in, for example, DBA/2J, Colla1r/r, and Tyr437His
mice.53,55–57 Why is RGC degeneration or axonal damage
absent in MMP-9 null mice despite a clear early-onset IOP
elevation? As we excluded both coincidental decreases in
TIMP levels and enzymatic compensation for deleted MMP-9
activity by MMP-2, MMP-3, and MMP-13, the most likely
explanation may lie either in MMP redundancy or in MMP-9
functioning in the retina. Increased MMP-9 activity in the RGC
layer has indeed been reported in diverse glaucoma models
and plays a key role in the promotion of RGC death, by
inducing degradation of laminin and subsequent detachment-
induced apoptosis of RGCs.58–60 Remarkably, MMP-9 null
mice subjected to an optic nerve ligation injury model are
protected from RGC death,17 suggesting that MMP-9 null mice
are protected from glaucomatous neurodegeneration. An
alternative explanation might be related to the presence of
collagens in the peripapillary ECM, which may, according to
preliminary findings (Supplementary Fig. S2), be affected in
the MMP-9 null mice. According to the mechanical stress
hypothesis, ocular hypertension-induced distortions of the
ECM surrounding the RGC axon bundles are at the basis of
glaucomatous damage. The qualitative composition of the
ECM may thus have a major impact on its stress resistance
and, therefore, on the susceptibility of RGC (axons) to
glaucomatous neurodegeneration.61,62
Therapeutic Implications
Several studies in POAG patients have linked decreased MMP-9
activity in the trabecular meshwork to the development of
ocular hypertension.33,34 The present results endorse a causal
role for MMP-9 and put forward this ECM-remodeling protease
as a potential target for novel IOP-lowering therapies.
Noteworthy, ocular hypertension has already been successfully
reversed via viral vector–mediated delivery of MMP-1 in the
trabecular meshwork of sheep with steroid-induced glauco-
ma.63,64 A similar, viral vector–mediated approach to overex-
press MMP-9 in the trabecular meshwork could be persued. On
the other hand, given its detrimental role in RGC degeneration,
direct manipulation of MMP-9 activity in the eye might be a
dangerous approach for the treatment of glaucoma. Alterna-
tively, the present data could be a starting point to identify
downstream molecules of MMP-9 regulation and novel targets
for baroprotective therapies.
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